Share this post on:

Product Name :
Brinzolamide/Brimonidine Tartrate

Search keywords :
Carbonic Anhydrase 2

drugId :
null

Target Vo:
Adrenergic receptors alpha-2

Target Vo Short Name :
ADRA2

Moa_Name:
Carbonic anhydrase II inhibitors

First Approval Country :
United States

First Approval Date Filter:
2013

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :
Alcon Inc

Active Indication_Name:
Ocular Hypertension

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ADAR1 Antibody (YA1658) Technical Information
EPX Antibody In Vitro
CDX2 Antibody: CDX2 Antibody is an unconjugated, approximately 34 kDa, rabbit-derived, anti-CDX2 monoclonal antibody. CDX2 Antibody can be used for: WB, IHC-P, ICC/IF, FC expriments in human, mouse, rat background without labeling.

Share this post on:

Author: Betaine hydrochloride